Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients
Background. Butyrylcholinesterase (BChE) is synthesized mainly in the liver and an important marker in many infectious/inflammatory diseases, but its role in acquired immunodeficiency syndrome (AIDS) patients is not clear. We wished to ascertain if BChE level is associated with the progression/progn...
Main Authors: | Lijun Xu, Biao Zhu, Ying Huang, Zongxing Yang, Jia Sun, Yan Xu, Jinlei Zheng, Sabine Kinloch, Michael T. Yin, Honglei Weng, Nanping Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/5201652 |
Similar Items
-
Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.
by: Patrick Sulzgruber, et al.
Published: (2015-01-01) -
Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
by: Leo Pezzementi, et al.
Published: (2011-01-01) -
Studies on acetylcholinesterase and butyrylcholinesterase
by: Kinsch, Evelyn Marie.
Published: (2012) -
Studies on acetylcholinesterase and butyrylcholinesterase
by: Kinsch, Evelyn Marie.
Published: (2012) -
Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
by: Leo Pezzementi, et al.
Published: (2011-02-01)